↓ Skip to main content

Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial

Overview of attention for article published in BMC Endocrine Disorders, November 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter
1 X user
patent
3 patents

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
100 Mendeley
Title
Treatment with PBI-4050 in patients with Alström syndrome: study protocol for a phase 2, single-Centre, single-arm, open-label trial
Published in
BMC Endocrine Disorders, November 2018
DOI 10.1186/s12902-018-0315-6
Pubmed ID
Authors

Shanat Baig, Vishy Veeranna, Shaun Bolton, Nicola Edwards, Jeremy W. Tomlinson, Konstantinos Manolopoulos, John Moran, Richard P. Steeds, Tarekegn Geberhiwot

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 100 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 11%
Researcher 9 9%
Student > Ph. D. Student 8 8%
Student > Doctoral Student 6 6%
Student > Master 4 4%
Other 10 10%
Unknown 52 52%
Readers by discipline Count As %
Medicine and Dentistry 17 17%
Nursing and Health Professions 11 11%
Biochemistry, Genetics and Molecular Biology 8 8%
Environmental Science 2 2%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 9 9%
Unknown 51 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2022.
All research outputs
#3,567,597
of 25,611,630 outputs
Outputs from BMC Endocrine Disorders
#124
of 878 outputs
Outputs of similar age
#74,002
of 447,611 outputs
Outputs of similar age from BMC Endocrine Disorders
#4
of 25 outputs
Altmetric has tracked 25,611,630 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 878 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,611 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.